Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study.

An increased risk of mortality in patients with hyperuricemia has been reported. We examined (1) the risk of all-cause and cardiovascular disease (CVD) mortality in untreated hyperuricemic patients who did not receive urate-lowering therapy (ULT), and (2) the impact of ULT on mortality risk in patie...

Full description

Bibliographic Details
Main Authors: Jiunn-Horng Chen, Joung-Liang Lan, Chi-Fung Cheng, Wen-Miin Liang, Hsiao-Yi Lin, Gregory J Tsay, Wen-Ting Yeh, Wen-Harn Pan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4684295?pdf=render